| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | postsynaptic density | 8.47e-05 | 451 | 66 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.25e-04 | 477 | 66 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.79e-04 | 503 | 66 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 2.34e-04 | 523 | 66 | 8 | GO:0098984 | |
| GeneOntologyCellularComponent | focal adhesion | 4.12e-04 | 431 | 66 | 7 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 4.85e-04 | 443 | 66 | 7 | GO:0030055 | |
| Domain | SOCS | 1.16e-05 | 2 | 64 | 2 | PF12610 | |
| Domain | SOCS4/SOCS5_dom | 1.16e-05 | 2 | 64 | 2 | IPR022252 | |
| Domain | SOCS_box | 2.97e-04 | 38 | 64 | 3 | PF07525 | |
| Domain | SOCS_box | 3.21e-04 | 39 | 64 | 3 | SM00969 | |
| Domain | SOCS | 3.21e-04 | 39 | 64 | 3 | PS50225 | |
| Domain | SOCS_box | 3.21e-04 | 39 | 64 | 3 | IPR001496 | |
| Domain | Iontro_rcpt | 1.71e-03 | 18 | 64 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 1.71e-03 | 18 | 64 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 1.71e-03 | 18 | 64 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 1.71e-03 | 18 | 64 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.71e-03 | 18 | 64 | 2 | SM00918 | |
| Domain | Lig_chan | 1.71e-03 | 18 | 64 | 2 | PF00060 | |
| Domain | PBPe | 1.71e-03 | 18 | 64 | 2 | SM00079 | |
| Domain | CH | 2.01e-03 | 73 | 64 | 3 | PS50021 | |
| Domain | SOCS | 2.11e-03 | 20 | 64 | 2 | SM00253 | |
| Domain | CH-domain | 2.17e-03 | 75 | 64 | 3 | IPR001715 | |
| Domain | Fibrinogen_a/b/g_C_2 | 3.04e-03 | 24 | 64 | 2 | IPR014715 | |
| Domain | - | 3.04e-03 | 24 | 64 | 2 | 4.10.530.10 | |
| Domain | Fibrinogen_C | 3.84e-03 | 27 | 64 | 2 | PF00147 | |
| Domain | FBG | 4.42e-03 | 29 | 64 | 2 | SM00186 | |
| Domain | - | 4.73e-03 | 30 | 64 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 4.73e-03 | 30 | 64 | 2 | IPR014716 | |
| Domain | EGF_LAM_2 | 4.73e-03 | 30 | 64 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 4.73e-03 | 30 | 64 | 2 | PS01248 | |
| Domain | FIBRINOGEN_C_1 | 5.37e-03 | 32 | 64 | 2 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 5.37e-03 | 32 | 64 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 5.37e-03 | 32 | 64 | 2 | PS51406 | |
| Domain | Laminin_EGF | 6.39e-03 | 35 | 64 | 2 | PF00053 | |
| Domain | EGF_Lam | 6.39e-03 | 35 | 64 | 2 | SM00180 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 22423360 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 28195529 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 31200002 | ||
| Pubmed | 2.52e-05 | 29 | 68 | 3 | 20972250 | ||
| Pubmed | Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling. | 3.75e-05 | 5 | 68 | 2 | 15590694 | |
| Pubmed | Molecular basis for recognition of Gly/N-degrons by CRL2ZYG11B and CRL2ZER1. | 3.75e-05 | 5 | 68 | 2 | 34214466 | |
| Pubmed | ATM activation is impaired in human cells defective in RecQL4 helicase activity. | 3.75e-05 | 5 | 68 | 2 | 30594395 | |
| Pubmed | 7.23e-05 | 41 | 68 | 3 | 12076535 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 22519731 | ||
| Pubmed | HSP90B1 RINT1 DST NLRP7 SPEF2 EIF2AK4 ALDH2 NCAPH OGDH TASOR2 IQGAP1 | 1.05e-04 | 1442 | 68 | 11 | 35575683 | |
| Pubmed | 1.19e-04 | 128 | 68 | 4 | 30995482 | ||
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | 1.53e-04 | 410 | 68 | 6 | 25814554 | |
| Pubmed | Common variants at 30 loci contribute to polygenic dyslipidemia. | 1.65e-04 | 54 | 68 | 3 | 19060906 | |
| Pubmed | HSP90B1 DST CELSR3 SYNJ1 ASB3 RIPK4 DNAAF9 ZNF583 ZNF879 IQGAP1 | 1.90e-04 | 1285 | 68 | 10 | 35914814 | |
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 1.97e-04 | 146 | 68 | 4 | 20686565 | |
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 19385048 | ||
| Pubmed | 2.05e-04 | 11 | 68 | 2 | 19270065 | ||
| Pubmed | Identification and characterization of essential genes in the human genome. | 2.45e-04 | 12 | 68 | 2 | 26472758 | |
| Pubmed | 2.54e-04 | 1084 | 68 | 9 | 11544199 | ||
| Pubmed | 2.73e-04 | 64 | 68 | 3 | 26511642 | ||
| Pubmed | Dissection of the mammalian midbody proteome reveals conserved cytokinesis mechanisms. | 2.90e-04 | 13 | 68 | 2 | 15166316 | |
| Pubmed | 2.90e-04 | 13 | 68 | 2 | 23990909 | ||
| Pubmed | 3.05e-04 | 660 | 68 | 7 | 32780723 | ||
| Pubmed | The HSP90 family of genes in the human genome: insights into their divergence and evolution. | 4.44e-04 | 16 | 68 | 2 | 16269234 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 4.67e-04 | 934 | 68 | 8 | 33916271 | |
| Pubmed | 5.03e-04 | 17 | 68 | 2 | 32548123 | ||
| Pubmed | Multiple roles of lymphatic vessels in peripheral lymph node development. | 7.00e-04 | 20 | 68 | 2 | 30355615 | |
| Pubmed | 7.00e-04 | 20 | 68 | 2 | 20714348 | ||
| Pubmed | 7.06e-04 | 360 | 68 | 5 | 33111431 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 7.50e-04 | 208 | 68 | 4 | 33230847 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 7.54e-04 | 1005 | 68 | 8 | 19615732 | |
| Pubmed | 9.28e-04 | 23 | 68 | 2 | 18971422 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 9.73e-04 | 582 | 68 | 6 | 20467437 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.01e-03 | 24 | 68 | 2 | 35746896 | |
| Pubmed | RBX2 maintains final retinal cell position in a DAB1-dependent and -independent fashion. | 1.10e-03 | 25 | 68 | 2 | 29361558 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 1.36e-03 | 621 | 68 | 6 | 22794259 | |
| Pubmed | 1.48e-03 | 29 | 68 | 2 | 18239623 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.61e-03 | 256 | 68 | 4 | 33397691 | |
| Pubmed | 1.68e-03 | 259 | 68 | 4 | 31162944 | ||
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 1.75e-03 | 121 | 68 | 3 | 31900314 | |
| Pubmed | 1.75e-03 | 121 | 68 | 3 | 22412018 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.79e-03 | 444 | 68 | 5 | 34795231 | |
| Pubmed | 1.91e-03 | 1440 | 68 | 9 | 30833792 | ||
| Pubmed | 1.91e-03 | 451 | 68 | 5 | 36168627 | ||
| Pubmed | 1.92e-03 | 125 | 68 | 3 | 29467281 | ||
| Interaction | FLII interactions | 6.37e-06 | 298 | 67 | 8 | int:FLII | |
| Interaction | HADHA interactions | ASXL1 HSP90B1 ANLN NAF1 RECQL4 LAMA4 ENTHD1 RIPK4 ALDH2 OGDH | 1.68e-05 | 567 | 67 | 10 | int:HADHA |
| GeneFamily | SH2 domain containing|Suppressors of cytokine signaling | 1.61e-04 | 8 | 44 | 2 | 764 | |
| GeneFamily | Fibrinogen C domain containing | 1.68e-03 | 25 | 44 | 2 | 554 | |
| Coexpression | GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN | 3.79e-07 | 179 | 67 | 7 | M8900 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.34e-07 | 188 | 68 | 6 | 50b27fc12347ca16bd62333baf345c83cb422a8f | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.68e-06 | 130 | 68 | 5 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-06 | 182 | 68 | 5 | 0fc45214f0b0766f69be6eff69cc4bec574023aa | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.17e-06 | 184 | 68 | 5 | 8ed22b1af04a711203293e7a8b3df6fb9222fad5 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 198 | 68 | 5 | 1fe60443c11d34b6d2671af8f06e0dedc8d1558b | |
| ToppCell | mLN-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 1.34e-05 | 199 | 68 | 5 | c81a194f8c2f120c6c4d74857912865a3c2fe1e7 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.34e-05 | 199 | 68 | 5 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.16e-05 | 126 | 68 | 4 | 94bd9cfe982b41a3114885173eab55feb0fbbbae | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.56e-05 | 129 | 68 | 4 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.57e-05 | 147 | 68 | 4 | 22d71cf92b957e5a8aa63b13157626d013d6752b | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 7.77e-05 | 148 | 68 | 4 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 7.98e-05 | 149 | 68 | 4 | a34d095b8e0fe59d69d84e4fd2fe4ccb82f92e4f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.84e-05 | 153 | 68 | 4 | 92a5307b8e4dcf9ee42134b4c0645f9d488df61a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-05 | 155 | 68 | 4 | 8b524c65fa5c901f70c7caae4ec7fd2859eaf227 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.30e-05 | 155 | 68 | 4 | ab539c04f10276ae919d82b1c75f99a84eb695bf | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.30e-05 | 155 | 68 | 4 | 9a27558c457f05808af07190b7a5006b047f1d58 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-05 | 155 | 68 | 4 | 7fe8b8c0c8a9e3190cfd52d3934509e6780e1717 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.53e-05 | 156 | 68 | 4 | 841d653d74c4de41d2f9a114f6ccb92d6a1ebc24 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.53e-05 | 156 | 68 | 4 | a917b3e799a7b2a3c7f36af61f2b69292c0fb5c0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 159 | 68 | 4 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 159 | 68 | 4 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 160 | 68 | 4 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 164 | 68 | 4 | d5bb57c321f2973836efc8990449494cc1fb87c7 | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue | 1.21e-04 | 166 | 68 | 4 | ae967570248cf86ca3ddf55e33bcbb3e4e3684bc | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue | 1.21e-04 | 166 | 68 | 4 | a176e87aa6eec81d1fb79a028f759182d11b567d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 167 | 68 | 4 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 169 | 68 | 4 | 2a21f2cef959526bfe3c8f081f4f7e9dd4e01a37 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 169 | 68 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 169 | 68 | 4 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-04 | 170 | 68 | 4 | badbe200e9d5003d23d115955b10b4ea767f6c26 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.33e-04 | 170 | 68 | 4 | 97df5ffb328196c46568975d2d97722bcc753bf5 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 171 | 68 | 4 | b113fbebb89056af0b9c775d2fb6552206a80467 | |
| ToppCell | Healthy/Control-Plasmablast|World / Disease group and Cell class | 1.39e-04 | 172 | 68 | 4 | d3bfcf5d936152b71cd90f955f9331709edd979e | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 1.39e-04 | 172 | 68 | 4 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-04 | 172 | 68 | 4 | 1bad7b19724e1b53ace7e05644215334c9f43910 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.42e-04 | 173 | 68 | 4 | a55f310c533432e9e26e400026a5b47245152976 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 173 | 68 | 4 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 173 | 68 | 4 | a7dee23b1d43d3070d502487af319ff81a9a747b | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 173 | 68 | 4 | 15af4a0f7516dbf5c93ba66a19aca073ebe30d04 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.42e-04 | 173 | 68 | 4 | 9c7386bf0a899882c733f0b4921a96afde032a7d | |
| ToppCell | Healthy/Control-Plasmablast|Healthy/Control / Disease group and Cell class | 1.45e-04 | 174 | 68 | 4 | 97d19ef3240a1f648c6befaabb9ce45ad469cbce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 176 | 68 | 4 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 1.55e-04 | 177 | 68 | 4 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.55e-04 | 177 | 68 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-04 | 177 | 68 | 4 | 15553c7cd7826c80086daa76af4224f32dde53a6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.62e-04 | 179 | 68 | 4 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.62e-04 | 179 | 68 | 4 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-04 | 180 | 68 | 4 | 2658a6be43d6d94767b4fc5af2d8632469a8a979 | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-04 | 181 | 68 | 4 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 182 | 68 | 4 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-04 | 182 | 68 | 4 | 4cd5eb13f78f4f377932c50ac2acb4ac0cd14c12 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.72e-04 | 182 | 68 | 4 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-04 | 183 | 68 | 4 | 54782c2e23bbeca5b683aa931393b1118da4aa37 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 1.80e-04 | 184 | 68 | 4 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-04 | 185 | 68 | 4 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 1.83e-04 | 185 | 68 | 4 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.83e-04 | 185 | 68 | 4 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.91e-04 | 187 | 68 | 4 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | Mast_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.95e-04 | 188 | 68 | 4 | 229d24b87e945c4d543d11ac70761e45175ba0e5 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 1.95e-04 | 188 | 68 | 4 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.95e-04 | 188 | 68 | 4 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-04 | 188 | 68 | 4 | 9fc3819aae5a2b2534cb131d467435b5cfc420d6 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.95e-04 | 188 | 68 | 4 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.95e-04 | 188 | 68 | 4 | 5e5d779ea079d3b2a1ef650b06b9f5cc1ffef5e7 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.99e-04 | 189 | 68 | 4 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-04 | 189 | 68 | 4 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-04 | 189 | 68 | 4 | aba941ba6ce7702418b3f470bde573d123c4aade | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 1.99e-04 | 189 | 68 | 4 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-04 | 189 | 68 | 4 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-04 | 189 | 68 | 4 | 3169476f98b7385706cb618c9ad64ae83a290ef0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-04 | 189 | 68 | 4 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-04 | 189 | 68 | 4 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 1.99e-04 | 189 | 68 | 4 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.99e-04 | 189 | 68 | 4 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|IPF / Disease state, Lineage and Cell class | 2.03e-04 | 190 | 68 | 4 | e539ebc0f4c5ee5dba86c614387be7d91338ad47 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|COPD / Disease state, Lineage and Cell class | 2.03e-04 | 190 | 68 | 4 | 006e31606d637033bc81333816ee332773d36b08 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.03e-04 | 190 | 68 | 4 | 07215e8f292cb54c670037aaf28393cddbe5548c | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 2.03e-04 | 190 | 68 | 4 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.03e-04 | 190 | 68 | 4 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-04 | 191 | 68 | 4 | 361b123c8289015206d5e706ab2c615d9a724179 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-04 | 191 | 68 | 4 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.07e-04 | 191 | 68 | 4 | 6cda82a994f4b205cf54590c979d7c9f3be2b4c8 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.07e-04 | 191 | 68 | 4 | 4257f02856f3510981e9f84d465d91448d6126e2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-04 | 191 | 68 | 4 | 011dc22c488369734749e839d65d52fe46b6a1a4 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.07e-04 | 191 | 68 | 4 | 2699e9bb872f2b561bb976dfdc2746e359bc9daf | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.07e-04 | 191 | 68 | 4 | 4b94c8b0183ae07d173646b7e7e1d9db04ec9637 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-04 | 192 | 68 | 4 | 690cf19e9b0b2ada80097c63eae827529aa5b6f3 | |
| ToppCell | cellseq-Immune-Hematopoietic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.11e-04 | 192 | 68 | 4 | a081624e81e6fca8bb8da58fc2809af451c7315c | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-04 | 192 | 68 | 4 | 3d6c4c5847ca1e44fa380403d25af45d5b51ee9b | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-04 | 192 | 68 | 4 | e0412964a3ee1bf3c0ef64f9a6f20f7e7835701e | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-04 | 192 | 68 | 4 | b5871247a5f3e970fa05b33fff21bef9d2ab5741 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.11e-04 | 192 | 68 | 4 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | distal-Hematologic-Basophil/Mast_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-04 | 193 | 68 | 4 | f22d0a2ea6bbdd625909ccb6a89aca89ab670306 | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|Myeloid / Disease state, Lineage and Cell class | 2.16e-04 | 193 | 68 | 4 | 80871d963c23a6befe58e5e60b7f7d1a1b227ce2 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 2.16e-04 | 193 | 68 | 4 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.16e-04 | 193 | 68 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | distal-Hematologic-Basophil/Mast_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-04 | 193 | 68 | 4 | dcdc1498726c68bf590bf84cb81e5f7fb7ba4d78 | |
| ToppCell | distal-3-Hematologic-Basophil/Mast_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-04 | 193 | 68 | 4 | 23c6c798525dad43eff792727902ea562bf373be | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.16e-04 | 193 | 68 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 193 | 68 | 4 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| Disease | allergic rhinitis | 2.29e-04 | 133 | 66 | 4 | EFO_0005854 | |
| Disease | triacylglycerol 52:2 measurement | 2.58e-04 | 55 | 66 | 3 | EFO_0010414 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 4.42e-04 | 66 | 66 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | Opioid use measurement | 5.08e-04 | 15 | 66 | 2 | EFO_0009937 | |
| Disease | Bipolar Disorder | 6.92e-04 | 477 | 66 | 6 | C0005586 | |
| Disease | progranulin measurement | 1.11e-03 | 22 | 66 | 2 | EFO_0004625 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.13e-03 | 91 | 66 | 3 | EFO_0004611, EFO_0005271 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.28e-03 | 95 | 66 | 3 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.32e-03 | 96 | 66 | 3 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | glucose measurement | 1.62e-03 | 380 | 66 | 5 | EFO_0004468 | |
| Disease | thrombocytopenia (is_implicated_in) | 1.67e-03 | 27 | 66 | 2 | DOID:1588 (is_implicated_in) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.75e-03 | 106 | 66 | 3 | EFO_0008317, EFO_0008596 | |
| Disease | Hyalinosis, Segmental Glomerular | 1.79e-03 | 28 | 66 | 2 | C0086432 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.89e-03 | 109 | 66 | 3 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | lysophosphatidylethanolamine 20:4 measurement | 1.92e-03 | 29 | 66 | 2 | EFO_0010370 | |
| Disease | Thrombocytopenia | 1.92e-03 | 29 | 66 | 2 | C0040034 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.94e-03 | 110 | 66 | 3 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.94e-03 | 110 | 66 | 3 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.94e-03 | 110 | 66 | 3 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | Breast Cancer, Familial | 2.06e-03 | 30 | 66 | 2 | C0346153 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSEAFNLWQINLHEL | 491 | Q86TW2 | |
| QENQAETHAWFTSRF | 206 | P32302 | |
| QFLSLEWDADEQAFN | 1586 | Q9P2K8 | |
| SQLGFHQSNQWAVDS | 416 | Q96GX5 | |
| TSQLQDNHWNFGTAL | 86 | Q49SQ1 | |
| WNNQSIDLNHNFADL | 426 | Q96SM3 | |
| NLFKNVTQANDFHNW | 1211 | Q86UQ4 | |
| VTQANDFHNWEDFLD | 1216 | Q86UQ4 | |
| LDHFQNSNIDQSFWE | 316 | Q8N6T3 | |
| QHRIDGSQNFNETWE | 286 | Q9Y5C1 | |
| SALNNEFFTHAAQSW | 306 | Q8IXJ9 | |
| AQAHAENNEFITWND | 506 | P46940 | |
| RNHFWEFFEEGANSN | 451 | Q13434 | |
| NNNLLTGWEEHTFDN | 961 | Q6ZRR7 | |
| VEQSFFNDWFSGHLN | 366 | O95864 | |
| SHWGEFSTQNVDQFI | 511 | Q8IYW4 | |
| NQESEFWLGNENLHQ | 156 | O75636 | |
| NLHQYNWIEESNGQT | 956 | Q6ZRS4 | |
| HNSLQDFINWLTQAE | 6601 | Q03001 | |
| SWEDDVNHSFAKQNS | 211 | Q9NQW6 | |
| DDGWNQIQFNLLDFT | 126 | Q9Y6A4 | |
| FHQSLTNNWEDHLAV | 136 | Q58FG0 | |
| INNEDNWIAHQDDFN | 71 | Q96BK5 | |
| NWIAHQDDFNQLLAE | 76 | Q96BK5 | |
| FEIHQGNFQEWITDT | 276 | Q9HC73 | |
| IVSSENNFFIWNLQH | 456 | Q8TCU5 | |
| NNDTQHIWESDSNEF | 216 | P14625 | |
| VLWEAQFGDFHNTAQ | 741 | Q02218 | |
| GWNSLHQASFQENAE | 146 | Q9Y575 | |
| DDTISINHNWVNGFN | 321 | Q9H9V9 | |
| AAEHLEAQAQNSQLW | 271 | Q8N4Y2 | |
| DLVAFEHQWTSFFAN | 231 | Q5TEA3 | |
| EHQWTSFFANFDTEI | 236 | Q5TEA3 | |
| NWNSSDYLHLNPDNF | 391 | P38567 | |
| DAEQQQFWEQFHKEA | 1231 | Q9NYC9 | |
| ATQDAHFNENLLWAG | 2251 | Q9NYQ7 | |
| AFFQEFAQSLNQSWQ | 276 | Q16099 | |
| FAQSLNQSWQENCDH | 281 | Q16099 | |
| DWSEQNSAFFQQPSH | 1101 | Q9Y3R0 | |
| NWSQNLQHFDSSAYN | 761 | Q16363 | |
| HWQEDAFFASQFLNG | 231 | O15296 | |
| HKQDFVAQWQADFNS | 1076 | Q9C093 | |
| AQAWFSAIHSNVNDL | 286 | Q13884 | |
| LHARIEQWNHNFSFD | 426 | O75159 | |
| EQTTDNRFFWNQSLH | 151 | O43426 | |
| EWNTTNAKQILNFFH | 276 | A6NDU8 | |
| ESCFLNEQFDHWAAQ | 401 | O94761 | |
| DGLWNNNQTQLFLEH | 271 | Q96D42 | |
| LHARIEQWNHNFSFD | 331 | Q8WXH5 | |
| WVFHEIDAQLQSSNA | 346 | Q9HCD6 | |
| NTFWQGDIDNFHDDV | 136 | Q8WX94 | |
| FQTTEAQHLFLQAFW | 86 | P56182 | |
| LNQDNAVSHHTWEFQ | 16 | P49221 | |
| DQFVLQSHAWFNVSS | 951 | P08514 | |
| DENSWFNLFVIHQNR | 206 | P49959 | |
| DQWTALHFAAQNGDE | 551 | P57078 | |
| IHPESFNLQWFFNDS | 136 | Q53R12 | |
| CNQIFINNEWHDAVS | 36 | P05091 | |
| GFQFTQWDSETHNES | 321 | Q15003 | |
| QHFESQQDLENKWSN | 196 | Q9NQ89 | |
| FWFSTDFDQHQNQPN | 201 | Q8TAW3 | |
| FQDWVEAADIFQNFS | 141 | Q5VZ03 | |
| ADWADNVFFLQLQQA | 551 | Q6NUQ1 | |
| FFQQDALTWNNEIHC | 231 | Q70EL3 | |
| YHQNANGSWDLNEDL | 686 | O00534 | |
| FDWHQDALSKSLQQN | 166 | Q9NRE2 | |
| GQNHFIKDSQWEQQA | 316 | Q6P2C0 | |
| VFFSQDEWLHLDSAQ | 21 | B4DU55 | |
| YESSLNFHNNNQEDW | 1866 | Q5VWN6 | |
| HDFVFQWQENETNGH | 161 | Q9NV72 | |
| SWQTFHQDTIFDIQQ | 161 | Q96ND8 | |
| WTEVFFLENDDQHNC | 1311 | O95405 | |
| EDFTEVHQNWNAHSS | 346 | Q96HR8 |